BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Kallmann Syndrome

Below is an extended Kallmann Syndrome research listing. Click here to return to the Kallmann Syndrome main in depth entry.

Recent Publications on Kallmann Syndrome:

PROKR2 missense mutations associated with Kallmann syndrome impair receptor signalling-activity.
Kallmann syndrome (KS) combines hypogonadism due to gonadotropin-releasing...
Direct Link
2nd October, 2008
CNRS UMR5203, Institut de Genomique Fonctionnelle, INSERM U661, and
Prokineticin-signaling pathway.
Prokineticin signaling comprises two secreted proteins (Prok-1 and Prok-2)...
Direct Link
1st October, 2008
Department of Surgery, University of Hong Kong, Pokfulam, Hong Kong,
Genetic control of pubertal timing.
PURPOSE OF REVIEW: Puberty is an important developmental and life stage...
Direct Link
27th September, 2008
Division of Pediatric Endocrinology, Rainbow Babies and Children's
Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice.
Idiopathic hypogonadotropic hypogonadism (IHH) with anosmia (Kallmann...
Direct Link
26th September, 2008
Harvard Center for Reproductive Endocrine Sciences and Reproductive
Essential requirement for zebrafish anosmin-1a in the migration of the posterior lateral line primordium.
Kallmann syndrome (KS) is a human genetic disease that impairs both cell...
Direct Link
10th September, 2008
INSERM Equipe Avenir, IFR Neurosciences (IFR 70), Hopital de la
Whole-Brain Voxel-Based Morphometry in Kallmann Syndrome Associated with Mirror Movements.
BACKGROUND AND PURPOSE: There are 2 main hypotheses concerning the cause...
Direct Link
5th September, 2008
Divisions of Radiology and Endocrinology and Metabolism, Department of
Genetic Analysis in Patients with Kallmann Syndrome: Coexistance of Mutations in Prokineticin Receptor 2 and KAL1.
Kallmann syndrome (KS) is characterized by the association of...
Direct Link
30th August, 2008
The prevalence of intragenic deletions in patients with idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.
Idiopathic hypogonadotropic hypogonadism (IHH) and Kallmann syndrome (KS)...
Direct Link
20th August, 2008
Section of Endocrinology, Diabetes and Metabolism, Department of Medicine,
Sex, smell and vasculitis: Henoch-Schonlein purpura in Kallmann's syndrome. 16th August, 2008
Internal Medicine, East Tennessee State University, USA.
LOSS-OF-FUNCTION MUTATIONS IN THE GENES ENCODING PROKINETICIN-2 OR PROKINETICIN RECEPTOR-2 CAUSE AUTOSOMAL RECESSIVE KALLMANN SYNDROME.
Context: Physiological activation of the prokineticin pathway has a...
Direct Link
7th August, 2008
Developmental Endocrinology Unit, Laboratory of Hormone and Molecular
New genes controlling human reproduction and how you find them. 4th July, 2008
Boston, Massachusetts.
Homozygous mutation in the prokineticin-receptor2 gene (Val274Asp) presenting as reversible Kallmann syndrome and persistent oligozoospermia: case report.
Prokineticin 2 (Prok2) or prokineticin-receptor2 (Prok-R2) gene mutations...
Direct Link
4th July, 2008
Department of Clinical and Experimental Medicine and Surgery,
Fibroblast growth factor 8 signaling through fibroblast growth factor receptor 1 is required for the emergence of gonadotropin-releasing hormone neurons.
GnRH neurons are essential for the onset and maintenance of reproduction....
Direct Link
21st June, 2008
Department of Integrative Physiology and Center for Neuroscience,
Mutations in prokineticin 2 and prokineticin receptor 2genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum.
CONTEXT: Mice deficient in prokineticin 2(PROK2) and prokineticin...
Direct Link
19th June, 2008
Reproductive Endocrine Unit of the Department of Medicine, Harvard
[Kallmann syndrome: a hystorical, clinical and molecular review] 18th March, 2008
Unidade de Neuroendocrinologia, Departamento de Medicina, Escola Paulista
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional